Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
12 December, 2018 19:14 IST
Fitch assigns 'BBB-(EXP)' rating to Adani Ports' proposed USD notes
Source: IRIS | 20 Jun, 2017, 01.29PM
Comments  |  Post Comment

Fitch Ratings has assigned India-based Adani Ports and Special Economic Zone (APSEZ, BBB-/Stable) proposed senior unsecured US dollar notes an expected rating of 'BBB-(EXP)'.

The agency expects the proceeds to be primarily used for refinancing the company's outstanding debt and its capital expenditure.

The notes are rated at the same level as APSEZ's senior unsecured debt rating as they will constitute direct, unsubordinated and unsecured obligations of APSEZ. The final rating is contingent upon the receipt of final documents conforming to information already received.

Shares of the company gained Rs 1.45, or 0.39%, to trade at Rs 375.15. The total volume of shares traded was 128,053 at the BSE (1.21 p.m., Tuesday).



Adani Ports and Special Economic Zone Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Ashok Leyland signs defence agreement with ELBIT Systems - 12-Dec-2018 09:41
Wipro launches automotive innovation center in Michigan - 12-Dec-2018 09:37
Liva Pharmaceuticals gets USFDA approval for its sANDA - Ranitidine Injection - 12-Dec-2018 09:35
Dr Reddy's Labs launches Omeprazole tablets in US market - 12-Dec-2018 09:31
Strides Vivimed JV receives consent for Albendazole tablets - 12-Dec-2018 09:27
Unichem Lab gets tentative nod for Tadalafil tablets - 12-Dec-2018 09:25
Zydus Wellness gets CCI approval for acquisition of Heinz India - 12-Dec-2018 09:20
Wipro Digital to expand Asia Pacific design capabilities in Australia - 11-Dec-2018 09:26
Wipro Digital to expand Asia Pacific design capabilities in Australia - 11-Dec-2018 09:24
Lupin receives tentative USFDA approval for Apixaban tablets - 11-Dec-2018 09:20
Lupin receives EIR from USFDA for Indore facility - 10-Dec-2018 16:10
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer